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Gap  junctional  intercellular  communication  (GJIC),  by which  glutathione  (GSH)  and  inorganic  ions  are
transmitted  to neighboring  cells,  is  recognized  as  being  largely  involved  in  toxic  processes  of  chemicals.
We  examined  acetaminophen  (APAP)-induced  hepatotoxicity  clinicopathologically  using  male  wild-type
mice  and  mice  lacking  the  gene  for connexin32,  a major  gap  junction  protein  in the liver  [knockout
(Cx32KO) mice].  When  APAP  was  intraperitoneally  administered  at  doses  of 100,  200,  or  300  mg/kg,
hepatic  centrilobular  necrosis  with  elevated  plasma  aminotransferase  activities  was  observed  in wild-
type  mice  receiving  300  mg/kg,  and  in Cx32KO  mice  given  100  mg/kg  or more.  At  200  mg/kg  or  more,
hepatic  GSH  and  GSSG  contents  decreased  signiﬁcantly  and  the  effect  was  more  severe  in wild-type  mice
than  in  Cx32KO  mice.  On the  other  hand,  markedly  decreased  GSH  staining  was  observed  in the  hepaticice centrilobular  zones  of  Cx32KO  mice  compared  to that  of wild-type  mice.  These  results  demonstrate  that
Cx32KO mice  are  more  susceptible  to APAP  hepatotoxicity  than wild-type  mice,  and  indicate  that  the
distribution  of GSH  of the centrilobular  zones  in the  hepatic  lobules,  rather  than  GSH  and  GSSG  contents  in
the  liver,  is important  in  APAP  hepatotoxicity.  In  conclusion,  Cx32  protects  against  APAP-induced  hepatic
centrilobular  necrosis  in  mice,  which  may  be  through  the  GSH  transmission  to neighboring  hepatocytes
by  GJIC.
. Introduction
Gap junctional intercellular communication (GJIC) is thought
o be important in maintaining tissue homeostasis; cell growth,
roliferation and differentiation; and embryonic development (De
aio et al., 2002; Vinken et al., 2006; Elias and Kriegstein, 2008;
ervé and Derangeon, 2013). Many reports have shown that GJIC
s related to a cellular event underlying tumor promotion processes
Yamasaki, 1996; Trosko, 2007; Upham et al., 2009). Furthermore,
he gap junction on the plasma membrane is a channel that con-
ects adjacent cells and contains connexons formed from hexamers
f connexins (Trosko and Ruch, 1998; De Maio et al., 2002). The
onnexins play a crucial role in cell–cell communication by small
olecules including reduced glutathione (GSH) and inorganic ions
s a second messenger, and in cellular metabolites (Sáez et al.,
989; Kumar and Gilula, 1996). GSH has been shown to protect ani-
als from hepatotoxicity due to xenobiotics by inactivating toxiclectrophiles; such protection is mediated through conjugations
atalyzed by glutathione S-transferase (GST). Certainly, oxidative
tress-related cell death induced by the chemical oxidant tert-butyl
∗ Corresponding author. Tel.: +81 538 42 4356; fax: +81 538 42 4350.
E-mail address: igarashi.isao.t6@daiichisankyo.co.jp (I. Igarashi).
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hydroperoxide was  reported to correlate closely with reductions in
GJIC and connexin protein expression, suggesting that a reduction
in GJIC caused toxic effects in epithelial cells (Hutnik et al., 2008).
In contrast, deﬁciency of GJIC was  reported to decrease tissue
injury by reducing transmission of death signals to neighboring
cells, e.g. transmission of radiation damage signals through the gap
junction from affected to non-affected cells has been demonstrated
(Little et al., 2002). Moreover, targeted disruption of the connexin32
(Cx32) gene has been reported to be associated with enhanced
occurrence of hepatic tumors, because apoptotic signals were not
transmitted to adjacent cells (Moennikes et al., 1999; Temme  et al.,
1997). More recently, transgenic rats carrying a dominant negative
mutation of the Cx32 gene (Cx32Tg  rats) were shown to be less
susceptible to hepatocellular damage induced by d-galactosamine,
carbon tetrachloride, or acetaminophen (APAP) than their wild-
type counterparts, because death or apoptotic signals were blocked
in Cx32Tg rats (Asamoto et al., 2004; Naiki-Ito et al., 2010).
The discrepancy between the aforementioned reports implies
that it is a critical issue whether Cx32 mediates resistance to tissue
injury and bystander cell death. The Cx32Tg rats were produced
mutants of Cx32 under control of the albumin promoter and the
transgene features deletion of 12 amino acids of the internal loop
of Cx32. Whereas, GJIC capacity of about 40% still remains through
the expression of endogenous Cx32 in Cx32Tg rats (Asamoto et al.,
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004). We  used Cx32 knockout (Cx32KO) mice in which the target-
ng construct was inserted in a frame into an EaeI site in exon 2
f the mouse Cx32 gene and the amount of connexin26 protein
xpressed was found to be lower than in wild-type liver; where
he total area of gap junction plaques was ≈1000-fold smaller than
n wild-type liver (Nelles et al., 1996).
The aim of the present study is to elucidate the resistance
o hepatic injury by GSH, which is controlled in Cx32 and GJIC
apacity. Accordingly, we focused our attention on APAP-induced
epatotoxicity as an analytical model, and compared clinicopatho-
ogical features in conjunction with hepatic metabolic enzymes
CYP), GSH and GSSG contents, and GSH-related enzymes between
ild-type and Cx32KO mice. APAP is generally safe at therapeutic
oses, however extremely high doses cause severe hepatotoxicity
n experimental animals (James et al., 2003a; Latchoumycandane
t al., 2007). Brieﬂy, at a safe dose, the majority of the administered
PAP is conjugated with sulfate or glucuronide, and then excreted
nto bile and urine, whereas a small portion of APAP is oxidized
y cytochrome P4502E1 (CYP2E1) to the hepatotoxic electrophile
-acetyl-p-benzoquinone imine (NAPQI), which is inactivated by
onjugation with GSH (Lee et al., 1996). At a toxic dose, sulfation
nd glucuronidation pathways become saturated, yielding much
ore NAPQI along with rapid depletion of hepatic GSH (Bajt et al.,
003). In this study, Cx32KO mice in which GJIC in the liver has been
lmost completely suppressed by inactivation of Cx32 gene expres-
ion, were treated APAP and the effect of GSH on modiﬁcation of
evere liver injury by GJIC impairment was examined.
. Materials and methods
.1. Animals
Wild-type C57BL/6 mice were purchased from Charles River
aboratories (Yokohama, Japan), and Cx32KO mice were kindly
rovided by Willecke and colleagues (Nelles et al., 1996). Cx32KO
ales were backcrossed with C57BL/6 females. The resulting het-
rozygote Cx32KO females of the F1 generation were then crossed
ith Cx32KO males. Due to the X-chromosomal linkage of the Cx32
ene, half of the male offspring of this cross were Cx32KO and half
ere wild-type. Cx32KO males (−/y) and their wild-type litter-
ates (+/+) were generated in our own facilities (Daiichi Sankyo Co.
td., Fukuroi, Shizuoka, Japan), and used at 20 weeks of age (body-
eight: 26–33 g). Males were chosen for this study to avoid effects
f the estrous cycle. To conﬁrm the genotype in Cx32KO mice, the
ips of their tails were excised and the tissue was analyzed by a
olymerase chain reaction (PCR). After identiﬁcation, the animals
ere individually housed in taper-type bracket cages in a barrier-
ustained room controlled at a temperature of 23 ± 1 ◦C, relative
umidity of 55 ± 5%, an illumination time of 12 h/day at an inten-
ity of about 200 luces, and ventilation of 10–15 cycles per h. Basal
iet (Certiﬁed Rodent Diet 5002: PMI  Nutrition International Inc.,
SA) and fresh tap water were given ad libitum. All experimen-
al procedures were performed in accordance with the Guidelines
or Animal Experimentation issued by the Japanese Association for
aboratory Animal Science (Japanese Association for Laboratory
nimal Science, 1987). The experimental protocol was  approved
y the Animal Experimental Committee of the Daiichi Sankyo Co.
td., Japan.
.2. Effects on factors related to the APAP toxicity in inactivation
f Cx32 gene expressionCx32 localization, GJIC capacity, CYP activities, GSH and GSSG
ontents, and GSH-related enzyme activities in the liver were inves-
igated to evaluate differences in naive wild-type and Cx32KO micelogic Pathology 66 (2014) 103– 110
(each 5 animals). These assessments were examined by the each
methods described below.
2.3. APAP treatment
Acetaminophen (APAP, Wako Pure Chemicals, Osaka, Japan) was
dissolved in 0.9% physiological saline (saline, Otsuka Pharmaceuti-
cal Co., Tokyo, Japan), and was intraperitoneally administered as a
single dose of 100, 200, or 300 mg/kg to groups of 5 mice each under
non-fasted conditions. Mice given saline alone (20 mL/kg) in the
same way served as the corresponding controls (saline). The dose
levels of APAP were selected to achieve mild to moderate hepa-
tocellular injury, but not excessive toxicity (Michael et al., 2001;
James et al., 2003b). One and 24 h after dosing, blood was  collected
via the inferior vena cava under ether anesthesia; all mice were
euthanized by exsanguination. Thereafter, a part of the excised liver
was ﬁxed in phosphate-buffered 10% formalin solution, and the
remaining portions were snap-frozen in liquid nitrogen (−80 ◦C)
until assayed.
2.4. Assessment of liver injury
As markers of hepatocellular injury, plasma alanine amino-
transferase (ALT) and aspartate aminotransferase (AST) activities
were measured by an autoanalyzer (Toshiba Medical Co. Ltd.,
Tochigi, Japan). For histopathological examinations, the ﬁxed tis-
sue of the left lateral, and left and right medial hepatic lobes
were trimmed, embedded in parafﬁn wax, cut at 3 m in thick-
ness, stained with hematoxylin–eosin (H&E) and examined with
a light microscope. The severity of hepatocellular degeneration
and necrosis was  scored using a grading system described previ-
ously (Aleksunes et al., 2005) with minor modiﬁcation. The scoring
was as follows, −: no injury; ±: minimal injury involving single to
few hepatocytes; +: mild injury affecting 10–25% of hepatocytes;
2+: moderate injury affecting 25–40% of hepatocytes; 3+: marked
injury affecting 40–50% of hepatocytes; 4+: severe injury affecting
more than 50% of hepatocytes.
2.5. Assays of hepatic CYP activities, GSH and GSSG contents and
GSH-related enzyme activities
CYP activities, GSH and GSSG contents, and GSH-related enzyme
activities in the liver were measured 1 h after saline or APAP treat-
ment to evaluate their ﬂuctuations before showing morphological
alterations (Gujral et al., 2002). Brieﬂy, microsomal and cytosolic
fractions from the liver of each mouse were prepared according
to the method of Omura and Sato (1964). As microsomal CYP
activities, 7-ethoxycoumarin O-deethylase (ECD) was estimated
by the method of Matsubara et al. (1983), and chlorzoxazone 6-
hydroxylation (CLZH) was estimated by the method of Peter et al.
(1990). Hepatic GSH and GSSG contents were measured by a DTNB-
glutathione reductase recycling assay with a Total Glutathione
Quantiﬁcation kit (Dojindo Laboratories, Kumamoto, Japan), and
was adjusted based on the wet  weight of the liver (nmol/mg liver
tissue). Cytosolic UDP-glucuronosyltransferase (UDP-GT) activ-
ity was  measured by the method of Bock et al. (1973), using
p-nitrophenol as a substrate; glutathione S-transferases (GST-
D and GST-C) were measured by the method of Habig et al.
(1974), using 1-chloro-2,4-dinitrobenzene and 1,2-dichloro-4-
nitrobenzene, respectively. Hepatic protein content was  measured
by the method of Lowry et al. (1951). The enzyme activities were
expressed as nmol/min/mg protein.
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.6. Hepatic GSH and Cx32 immunohistochemistry
For samples collected 1 h after administration of saline or APAP,
he frozen left lobe of the liver was sectioned at 8 m in thickness
ith a cryostat (Tissue-Tek Cryo3, Sakura Fintek Japan Co., Tokyo,
apan) at −20 ◦C. For GSH immunostaining, the frozen sections were
xed with 2% glutaraldehyde and 1% paraformaldehyde in phos-
hate buffered saline (PBS, pH 7.4) at 4 ◦C for 5 min. After washing
 times in ice-cold PBS, the specimens were incubated with rab-
it anti-GSH polyclonal antibody (Chemicon International Inc., CA,
:2000 dilution) for 30 min  at room temperature, and incubated
ith ﬂuorescence-labeled second antibody for 20 min. After the
ections were washed 3 times in PBS, they were mounted in glycerol
nd observed with a ﬂuorescence microscope (BX51TRF, Olympus
o., Tokyo, Japan). The slides were observed by the pathologist.
For Cx32 immunostaining, the sections were air-dried for 30 min
t room temperature, and immersed in acetone at −20 ◦C for 5 min
or ﬁxation. After washing 3 times in ice-cold 0.01 M PBS, the spec-
mens were incubated with a polyclonal anti-rat Cx32 antibody
Zymed Laboratories Inc., South San Francisco, CA, 1:1000 dilution)
or 60 min  at room temperature. After the sections were washed
 times in PBS, they were incubated with biotin-labeled rabbit
mmunoglobulin (Dako Cytomation, Kyoto, Japan, 1:100 dilution)
or 30 min  at room temperature. Subsequently, they were incu-
ated with ﬂuorescence-labeled streptavidin (Dako Cytomation,
:30 dilution) for 60 min  at room temperature. After the sections
ere washed 3 times in PBS, they were mounted in glycerol and
bserved with the ﬂuorescence microscope.
.7. Incision loading/dye transfer assay
To detect GJIC capacity on hepatocytes, an incision loading/dye
ransfer (IL/DT) assay (Hu et al., 2002) was performed in wild-type
nd Cx32KO mice; liver samples were collected 1 h after saline or
PAP dosing. The left lobe of the liver was placed on a plastic plate.
wo incisions (7–8 mm long and 1–2 mm depth) were made on the
ig. 1. Hepatic Cx32 immunostaining (A and C) and dye-transfer of Lucifer Yellow (B and
ocalization of Cx32 protein (arrows) on the hepatocyte membranes only in naive wild-
agniﬁcation: 100×.logic Pathology 66 (2014) 103– 110 105
surface of each specimen with a sharp blade. A ﬂuorescent dye con-
taining 0.5% Lucifer Yellow (Sigma, St. Louis, MO) in 0.05 M PBS was
put into the incisions and the sample was  kept for 3 min at room
temperature. The tissue was  washed with 0.05 M PBS, and ﬁxed in
phosphate-buffered 10% formalin solution overnight at room tem-
perature. The tissue was  quickly washed with distilled water, and
routinely processed for embedding in parafﬁn wax. Sections (5 m)
for GJIC analysis were prepared by cutting the parafﬁn block per-
pendicular to an incision line. Areas stained with Lucifer Yellow
were detected with the ﬂuorescence microscope.
2.8. Statistics
Quantitative data are expressed as the group mean and standard
derivation (SD), and differences between the control and APAP-
treated groups were statistically analyzed by Dunnett’s test. For
hepatic GSH and GSSG contents, the signiﬁcance of the difference
between wild-type and Cx32KO mice at each dose was  analyzed by
Student’s t-test. The p value for statistical signiﬁcance was deﬁned
as less than 5%.
3. Results
3.1. Hepatic Cx32 localization, GJIC capacity and drug
metabolizing factors in naive mice
Endogenous Cx32 proteins and GJIC capacity on the hepatocyte
membranes were examined by Cx32 immunohistochemistry and
IL/DT assay, respectively. Both Cx32 proteins and GJIC capacity were
abundant in wild-type mice, but they were extremely low or absent
in Cx32KO mice (Fig. 1). No signiﬁcant differences in hepatic CYP
activities such as ECD and CLZH, or GSH and GSSG contents and
GSH-related enzyme activities such as UDP-GT, GST-D and GST-C
were observed between naive wild-type and Cx32KO mice (data
not shown).
 D). (A and B) Naive wild-type mice. (C and D) Naive Cx32KO mice. Note diffusely
type mice and low or deﬁcient GJIC capacity (asterisks) in Cx32KO mice. Original
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Table  1
Clinicopathological ﬁndings in the liver of male Wild-type or Cx32KO mice treated intraperitoneally with acetaminophen (APAP) at 100, 200, or 300 mg/kg.
Time after treatment Mice Dose (mg/kg) n Plasma
ALT (U/L) AST (U/L) Score of hepatic necrosis
− ± + 2+ 3+ 4+
1 h
Wild-type Saline 5 36.8a ± 7.05 60.6 ± 10.7 0b 0 0 0 0 0
APAP  100 5 55.2 ± 38.9 73.6 ± 35.7 0 0 0 0 0 0
APAP  200 5 38.6 ± 11.5 63.6 ± 21.7 0 0 0 0 0 0
APAP  300 5 37.4 ± 6.2 60.8 ± 14.4 0 0 0 0 0 0
Cx32KO Saline 5 130.2 ± 195.3 161.4 ± 215.7 0 0 0 0 0 0
APAP  100 5 55.2 ± 27.5 80.6 ± 36.4 0 0 0 0 0 0
APAP  200 5 48.4 ± 32.3 71.6 ± 41.1 0 0 0 0 0 0
APAP  300 5 42.0 ± 19.5 57.0 ± 23.6 0 0 0 0 0 0
24  h
Wild-type Saline 5 24.1 ± 4.5 36.6 ± 3.1 0 0 0 0 0 0
APAP  100 5 26.6 ± 7.3 41.0 ± 8.3 0 0 0 0 0 0
APAP  200 5 45.4 ± 20.7 48.0 ± 10.3 0 0 0 0 0 0
APAP  300 5 8647 ± 8081* 3707 ± 3896* 0 0 1 2 2 0
Cx32KO Saline 5 38.4 ± 22.9 58.2 ± 12.1 0 0 0 0 0 0
APAP  100 5 3011 ± 1114* 981.6 ± 336.9* 0 0 3 2 0 0
APAP  200 5 6965 ± 1843* 3383 ± 851.7* 0 0 0 2 3 0
APAP  300 5 8960 ± 1359* 3514 ± 505.9* 0 0 0 0 3 2
The score of hepatic injuries was shown in Section 2.
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(a Values of plasma aminotransferase were expressed as the group mean ± SD.
b Number of animals showing the histopathological lesion in the group.
* p < 0.05, signiﬁcant difference from the control group (saline) in the respective 
.2. Clinicopathological aspects in wild-type and Cx32KO mice
iven APAP
In samples collected 1 h after APAP treatment, neither differ-
nces in plasma aminotransferase (ALT and AST) activities nor
epatic histopathology were noted between wild-type and Cx32KO
ice (Table 1). Decreases in hepatic GSH and GSSG contents were
een in both wild-type and Cx32KO mice given 200 mg/kg or more,
nd the reduction was much more severe in the former than in the
atter (Fig. 2). No differences in hepatic CYP or GSH-related enzyme
ctivities were seen between saline and APAP treatment or the two
inds of mice (data not shown).
ig. 2. Hepatic GSH and GSSG contents of wild-type and Cx32KO mice 1 h after
 single ip injection of acetaminophen (APAP). Animals given 0.9% saline solu-
ion  in the same way  served as controls. Values represent the mean ± SEM
f  5 animals. *p < 0.05, signiﬁcant difference between wild-type and Cx32KO
ice  (t-test). #p < 0.05, signiﬁcant difference from the wild-type control group
Dunnett’s test). $p < 0.05, signiﬁcant difference from the Cx32KO control group
Dunnett’s test).Dunnett’s test).
In samples collected 24 h after APAP treatment, severe hepa-
tocellular necrosis in the centrilobular to middle zones elevated
in plasma aminotransferase activities were observed in wild-type
mice given 300 mg/kg, and in Cx32KO mice given 100 mg/kg or
more (Table 1 and Fig. 3).
In the immunohistochemical examination at 1 h after APAP
treatment, hepatic GSH staining in wild-type mice decreased dif-
fusely in the hepatic lobules at 200 mg/kg APAP, and decreased
focally in the centrilobular zones at 300 mg/kg. In Cx32KO mice,
decreases in GSH staining of the centrilobular zones were observed
at 200 mg/kg APAP and more marked decreases were noted at
300 mg/kg APAP (Fig. 4). Little change in hepatic GSH staining
was seen in wild-type and Cx32KO mice receiving 100 mg/kg
APAP (data not shown) compared to the corresponding saline
controls (Fig. 4).
3.3. Hepatic Cx32 localization and GJIC capacity at 1 h later in
wild-type mice given APAP
Since endogenous Cx32 proteins and GJIC capacity on the hep-
atocyte were scarcely seen in Cx32KO mice as mentioned above,
the effect of APAP treatment was  examined only in wild-type mice.
Decreases in hepatic Cx32 proteins and partial reductions of GJIC
capacity in the centrilobular hepatocytes were observed only at
300 mg/kg APAP (Fig. 5).
4. Discussion
Based on immunohistochemical and dye transfer techniques,
both endogenous Cx32 proteins and GJIC capacity were extremely
low or absent on the hepatocyte membranes in naive Cx32KO mice,
whereas they were observed obviously in naive wild-type mice.
Neither signiﬁcant differences in basal hepatic CYP activities nor
GSH-related enzyme activities were seen between the two kinds of
mice. These ﬁndings indicated that Cx32KO mice can be used as a
GJIC deﬁcient model with normal metabolic function in the liver.
After intraperitoneal (ip) treatment with APAP, Cx32KO mice
are more susceptible to APAP-induced centrilobular necrosis
than wild-type mice based on clinicopathological ﬁndings and
evaluation of the dose response relationship 24 h after APAP treat-
ment, although no statistical differences in CYP or GSH-related
I. Igarashi et al. / Experimental and Toxicologic Pathology 66 (2014) 103– 110 107
F  H) m
A lar nec
i tion: 
e
A
t
m
d
a
u
B
i
i
t
r
e
m
a
n
i
tig. 3. Hepatic histopathology in wild-type (A, C, E and G) and Cx32KO (B, D, F and
PAP  200 mg/kg. (G and H) APAP 300 mg/kg. Note considerable severe hepatocellu
n  Cx32KO mice given 100 mg/kg or more. CV: central vein. H&E. Original magniﬁca
nzymes activities were noted between these two  mice 1 h after
PAP treatment. It was considered that GJIC deﬁciency may  con-
ribute to enhanced hepatotoxicity without involvement of hepatic
etabolic function by APAP.
Hepatic GSH was reported to be a rate-determining protein for
etoxiﬁcation of APAP hepatotoxicity (Bajt et al., 2003). GSH is
bundantly contained in the periportal zone of the hepatic lob-
les, and spreads from cell to cell via GJIC (Frankfurt et al., 1991;
arhoumi et al., 1993; Chen et al., 1998). In our study, reductions
n hepatic GSH and GSSG contents and decreases in GSH staining
n Cx32KO mice were relatively mild compared to those in wild-
ype mice. In APAP treatment, hepatic GSH and GSSG reduction
eﬂects extremely well the hepatic GSH reduction in mice (McGill
t al., 2012; Williams et al., 2013). Therefore, 1 h after APAP treat-
ent, hepatic GSH and GSSG contents were considered to exhibit GSH amount contained in the whole liver, whereas the immu-
ostaining of GSH was reveal zonal reduction of staining intensity
n the liver. Decrease in GSH staining intensity was  shown in cen-
rilobular hepatocytes in Cx32KO in comparison to that in wild-typeice 24 h after the treatment. (A and B) Saline. (C and D) APAP 100 mg/kg. (E and F)
rosis in the centrilobular to middle zones in wild-type mice given 300 mg/kg, and
100×.
mice, but centrilobular necrosis of hepatocytes was not noted 1 h
after APAP treatment in both animals. Taken together, the possi-
bility was raised that hepatic GSH consumed for detoxiﬁcation of
NAPQI was replenished rapidly in wild-type mice in the centrilob-
ular hepatocytes, but not in Cx32KO mice. Brieﬂy, the lack of GSH
translocation via GJIC in the centrilobular hepatocytes may  con-
tribute to the enhanced APAP hepatotoxicity in Cx32KO mice, since
GSH synthesized in the hepatic periportal zone would be provided
to the centrilobular zone, where GSH consumption was accelerated.
In other words, GSH-detoxiﬁcation was  more effective in wild-type
mice than in Cx32KO mice, and APAP hepatotoxicity in Cx32KO
mice was  thought to be enhanced by the decreased cytosolic GSH
in the centrilobular hepatocytes.
In wild-type mice given APAP, decreased hepatic Cx32 pro-
teins and partially depressed GJIC capacity in the centrilobular
hepatocytes were observed only at 300 mg/kg. These ﬁndings may
be supported by the above notion that the GSH  translocation via
GJIC plays a critical role in APAP hepatotoxicity, because clini-
copathological changes and hepatic Cx32/GJIC damage occurred
108 I. Igarashi et al. / Experimental and Toxicologic Pathology 66 (2014) 103– 110
Fig. 4. Hepatic GSH immunostaining of wild-type (A, C and E) and Cx32KO (B, D and F) mice 1 h after the treatment. (A and B) Saline. (C and D) APAP 200 mg/kg. (E and F)
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APAP  300 mg/kg. Note decreased hepatic GSH staining (asterisk) in the hepatic lob
SH  staining (asterisks) in wild-type and Cx32KO mice given 300 mg/kg. CV: centra
imultaneously at 300 mg/kg APAP. Therefore, effective NAPQI
etoxiﬁcation was likely to be achieved by GSH supplied from
eighboring intact cells to damaged cells.
Recently, it has been reported that Cx32Tg rats under control
f the albumin promoter have abnormal gap junction structures
n hepatocyte membranes and disruption of GJIC due to mutation
f Cx32 proteins (Asamoto et al., 2004; Hokaiwado et al., 2005).
n contrast to our results, Naiki-Ito et al. (2010) reported that the
otential for APAP hepatotoxicity was much less in Cx32Tg rats
han in littermate wild-type rats, suggesting that apoptosis medi-
ted by Cx43 (another connexin protein) may  be a principal process
f APAP hepatotoxicity, regulated by GJIC formed by Cx32. The rea-
ons for the discrepancy between the results of Cx32KO mice and
x32Tg rats may  be that there were large differences in exper-
mental conditions such as the route of administration of APAP
intragastric administration for the study by Naiki-Ito et al., 2010
s. ip injection for ours), dosage levels (250, 500, and 1000 mg/kg vs.
00, 200, and 300 mg/kg) and composition of the vehicle solution
0.5% methylcellulose vs. saline). As a result, there were very strik-
ng differences in morphological lesions in the liver (mild cell death
ith ballooning vs. severe cell death with zonal necrosis) between
he studies.
A species difference between mice and rats in susceptibility to
PAP-induced hepatotoxicity was recognized. For example, micend centrilobular zones of Cx32KO mice given 200 mg/kg and marked decreases in
. Original magniﬁcation: 100×.
are highly susceptible to hepatotoxic effects of APAP, although rats
are quite resistant (Moldéus, 1978; Jemnitz et al., 2008). Likewise,
the minimal hepatotoxic dose after a single ip injection of APAP was
reported to be 300 mg/kg for male C57BL/6 mice (Fujimoto et al.,
2009), and 1000 mg/kg for male Sprague-Dawley rats (Kamanaka
et al., 2003) under non-fasted conditions; these animals corre-
spond to the original strain of Cx32KO mice and Cx32Tg rats,
respectively. Based on the above information, the potential for hep-
atoxicity is higher in mice than in rats.
Regarding APAP-induced hepatic lesions, it was  reported that
necrosis was  observed in mice (Gujral et al., 2002), whereas apopto-
sis with activated caspase 3 was  mainly observed in rats (Naiki-Ito
et al., 2010). No changes in caspase 3 were seen in the liver of
mice treated with APAP (Lawson et al., 1999; Williams et al., 2011).
According to the previous reports of a terminal deoxynucleotidyl
transferase-mediated dUTP nick end labeling (TUNEL) assay or elec-
tron microscopy analysis, the onset of apoptosis has been reported
to be absent in the liver of mice receiving a toxic dose of APAP
(Jacob et al., 2007). In our study, the TUNEL assay was not performed
because cells in the zonal lesions showed no indication of apoptosis,
such as chromatin condensation or shrunken cytoplasm. Mean-
while, it has been reported that apoptosis occurs as a consequence
of oxidative stress when the GSH content is sufﬁcient to detoxify
toxic metabolites, whereas cells die by necrosis when the GSH is
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iig. 5. Hepatic Cx32 immunostaining (A, C and E) and incision loading/dye transfe
PAP  200 mg/kg. (E and F) APAP 300 mg/kg. Note reduced Cx32 proteins (asterisk) in
embranes of wild-type mice given 300 mg/kg. CV: central vein. Original magniﬁca
ery low in hepatocytes (Hentze et al., 2003; Vairetti et al., 2005).
his implies that mice may  be more susceptible to reduction of GSH
aused by APAP treatment than rats and severe hepatic necrosis
ather than apoptosis was induced in our Cx32KO mice hepatotoxi-
ity model. Therefore, when cell-to-cell transfer of GSH is inhibited
ue to impairment of GJIC, marked decreases in GSH that would
ead to necrosis might be the main result in Cx32KO mice.
Interestingly, the hepatotoxic potential of d-galactosamine or
arbon tetrachloride was reported to be lower in Cx32Tg rats than
n littermate wild-type rats, which is the same trend as in APAP hep-
totoxicity (Asamoto et al., 2004). These two hepatotoxicants also
nduced apoptosis in rat hepatocytes when GSH was  not depleted
nd the fact that cell damage and oxidative stress were less severe
Shi et al., 1998; Sun et al., 2003).
Considering both these observations, there may  be basic differ-
nces between the involvement of GJIC in the transmission of GSH
r apoptosis signals in our study and previous reports. We  believe
hat these differences will be the critical factors of Cx32 mediating
esistance to tissue injury and bystander cell death.
Although the mechanism underlying the difference between
x32KO mice and Cx32Tg rats remains to be elucidated, a
ifference in the detoxiﬁcation aspect in Cx32 expression with
JIC-deﬁcient structure seems to be a critical factor affect-
ng the modiﬁed APAP hepatotoxicity. In fact, Cx32 mediating (B, D and F) in wild-type mice 1 h after the treatment. (A and B) Saline. (C and D)
entrilobular zone and partial reductions (arrow) of GJIC capacity on the hepatocyte
100×.
gap junction-independent resistance to cellular injury has been
reported (Lin et al., 2003). In order to clarify the role of Cx32
proteins, further investigations are needed to collect investigation
data, e.g. sensitivity of hepatotoxicity in other hepatotoxicants in
Cx32KO mice or Cx32Tg rats including the relationship between
necrosis or apoptosis related factor and GJIC.
In conclusion, Cx32 protects against APAP-induced hepatic
centrilobular necrosis in mice, which may  be through the GSH
transmission to neighboring hepatocytes by GJIC.
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